Study reveals new effects of the investigational MS drug daclizumab
Bethesda, Maryland–(ENEWSPF)–August 1, 2012. Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). Their discovery helps define the effects of one of the newest drugs under investigation for treating MS — daclizumab — and could lead to a new class of drugs for treating MS and other autoimmune disorders.
In these disorders,…
